The effects of a chronic treament with riclopidine on 24 cerebrovascular patients with enhanced platelet function are reported. A significant increase of platelet aggregate ratio (P.A.R.) during the treatment, and similar significant decrease after the interruption of the therapy, has been observed.
|Number of pages||6|
|Journal||Current Therapeutic Research|
|Publication status||Published - 1983|
ASJC Scopus subject areas